Brain 17 Vienna
|
L1.1 ESTRO WHO CNS 2016 - AW |
1 |
|
L1.2 Modern imaging of CNS tumours - RB |
12-13 |
|
L1.3 Current Surgical Approaches in Brain Tumours - RB |
106-107 |
|
L1.4 Radiotherapy – Preparing the patient for treatment - GP |
242-243 |
|
L1.5 Radiotherapy- treatment techniques wide field irradiation CS and WBRT - KD |
334-335 |
|
L1.6 Localised radiotherapy techniques - MB |
410-411 |
|
L1.7 Radiotherapy – Radiation Tolerance of the Brain - GP |
592-593 |
|
L1.8 Systemic therapy issues - PR |
708-709 |
|
L2.1 Management of grade II and III astrocytic tumors- GP |
776-777 |
|
L2.2 Management of 1p 19q co-deleted tumors - PR |
914-915 |
|
L2.3 Management of glioblastoma - AC |
984-985 |
|
L2.4 Management of ependymoma of the brain and spinal cord - SJ |
1074-1075 |
|
L2.5 Management of cranial germ cell tumours - MB |
1144-1145 |
|
L2.6 Primary CNS lymphoma - PR |
1254-1255 |
|
L2.7a Management of medulloblastoma - KD |
1322-1323 |
|
L2.7b Management of medulloblastoma - DH |
1372-1373 |
|
L2.8a Management of pilocytic astrocytoma in children - DH |
1488-1489 |
|
L2.8b Management of pilocytic astrocytoma in children - SJ |
1598-1599 |
|
L2.9 Impact of molecular understanding of brain metastases on clinical practice - MP |
1664-1665 |
|
L3.1 Clinical trials in neurooncology - PR |
1732-1733 |
|
L3.2 Management of skull base tumours - SJ |
1808-1809 |
|
L3.3 Management of benign tumours - SJ |
1980-1981 |
|
L3.4 Management of brain metastases - MB |
2080-2081 |
|
L3.5 Supportive care of brain tumor patients |
2304-2305 |
|
C1. cases day 1 - KD |
2376-2377 |
|
C2.1 Management of high grade glioma in the eldery - AC |
2408-2409 |